128 related articles for article (PubMed ID: 12379583)
1. Hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin prevents cardiac hypertrophy induced by pressure overload and inhibits p21ras activation.
Indolfi C; Di Lorenzo E; Perrino C; Stingone AM; Curcio A; Torella D; Cittadini A; Cardone L; Coppola C; Cavuto L; Arcucci O; Sacca L; Avvedimento EV; Chiariello M
Circulation; 2002 Oct; 106(16):2118-24. PubMed ID: 12379583
[TBL] [Abstract][Full Text] [Related]
2. Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis.
Luo JD; Zhang WW; Zhang GP; Guan JX; Chen X
Clin Exp Pharmacol Physiol; 1999 Nov; 26(11):903-8. PubMed ID: 10561812
[TBL] [Abstract][Full Text] [Related]
3. Simvastatin prevents load-induced protein tyrosine nitration in overloaded hearts.
Nadruz W; Lagosta VJ; Moreno H; Coelho OR; Franchini KG
Hypertension; 2004 May; 43(5):1060-6. PubMed ID: 15023931
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin prevents cardiac hypertrophy in vitro and in vivo via JAK/STAT pathway.
Liu J; Shen Q; Wu Y
Life Sci; 2008 May; 82(19-20):991-6. PubMed ID: 18400235
[TBL] [Abstract][Full Text] [Related]
5. Lovastatin prevents angiotensin II-induced cardiac hypertrophy in cultured neonatal rat heart cells.
Oi S; Haneda T; Osaki J; Kashiwagi Y; Nakamura Y; Kawabe J; Kikuchi K
Eur J Pharmacol; 1999 Jul; 376(1-2):139-48. PubMed ID: 10440099
[TBL] [Abstract][Full Text] [Related]
6. Effects of simvastatin on left ventricular hypertrophy and function in rats with aortic stenosis.
Luo JD; Zhang WW; Zhang GP; Liu XH; Guan JX
Zhongguo Yao Li Xue Bao; 1999 Apr; 20(4):345-8. PubMed ID: 10452122
[TBL] [Abstract][Full Text] [Related]
7. [Sympathetic nerve in rat with pressure overload left ventricular hypertrophy].
Liao Y; Qu XF; Liu L; Dong XM; Yin DC
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(34):2412-5. PubMed ID: 20137696
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin prevents isoproterenol-induced cardiac hypertrophy through modulation of the JAK/STAT pathway.
Al-Rasheed NM; Al-Oteibi MM; Al-Manee RZ; Al-Shareef SA; Al-Rasheed NM; Hasan IH; Mohamad RA; Mahmoud AM
Drug Des Devel Ther; 2015; 9():3217-29. PubMed ID: 26150695
[TBL] [Abstract][Full Text] [Related]
9. Modulation of impact of high fat diet in pathological and physiological left ventricular cardiac hypertrophy by fluvastatin.
Singh R; Krishan P
Biomed Pharmacother; 2010 Mar; 64(3):147-53. PubMed ID: 20053524
[TBL] [Abstract][Full Text] [Related]
10. Effects of simvastatin on activities of endogenous antioxidant enzymes and angiotensin-converting enzyme in rat myocardium with pressure-overload cardiac hypertrophy.
Luo JD; Zhang WW; Zhang GP; Zhong BH; Ou HJ
Acta Pharmacol Sin; 2002 Feb; 23(2):124-8. PubMed ID: 11866871
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin activates the PPARĪ³-dependent pathway to prevent left ventricular hypertrophy associated with inhibition of RhoA signaling.
Zou C; Qi H; Liu ZH; Han L; Zhao C; Yang X
Tex Heart Inst J; 2013; 40(2):140-7. PubMed ID: 23678211
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin prevents large blood pressure variability induced aggravation of cardiac hypertrophy in hypertensive rats by inhibiting RhoA/Ras-ERK pathways.
Takayama N; Kai H; Kudo H; Yasuoka S; Mori T; Anegawa T; Koga M; Kajimoto H; Hirooka Y; Imaizumi T
Hypertens Res; 2011 Mar; 34(3):341-7. PubMed ID: 21124329
[TBL] [Abstract][Full Text] [Related]
13. Simvastatin reverses cardiac hypertrophy caused by disruption of the bradykinin 2 receptor.
Osorio JC; Cheema FH; Martens TP; Mahmut N; Kinnear C; Gonzalez AM; Bonney W; Homma S; Liao JK; Mital S
Can J Physiol Pharmacol; 2008 Sep; 86(9):633-42. PubMed ID: 18758513
[TBL] [Abstract][Full Text] [Related]
14. [Simvastatin attenuated cardiac hypertrophy via inhibiting JAK-STAT pathways].
Wu Y; Liu J
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Aug; 36(8):738-43. PubMed ID: 19100119
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin AT1 receptor inhibition. Effects on hypertrophic remodeling and ACE expression in rats with pressure-overload hypertrophy due to ascending aortic stenosis.
Weinberg EO; Lee MA; Weigner M; Lindpaintner K; Bishop SP; Benedict CR; Ho KK; Douglas PS; Chafizadeh E; Lorell BH
Circulation; 1997 Mar; 95(6):1592-600. PubMed ID: 9118530
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro.
Kojima M; Shiojima I; Yamazaki T; Komuro I; Zou Z; Wang Y; Mizuno T; Ueki K; Tobe K; Kadowaki T
Circulation; 1994 May; 89(5):2204-11. PubMed ID: 8181146
[TBL] [Abstract][Full Text] [Related]
17. Activation of endothelial nitric oxide synthase by a vanadium compound ameliorates pressure overload-induced cardiac injury in ovariectomized rats.
Bhuiyan MS; Shioda N; Shibuya M; Iwabuchi Y; Fukunaga K
Hypertension; 2009 Jan; 53(1):57-63. PubMed ID: 19029487
[TBL] [Abstract][Full Text] [Related]
18. HMG-CoA reductase inhibitors inhibit rat propylthiouracil-induced goiter by modulating the ras-MAPK pathway.
Laezza C; Mazziotti G; Fiorentino L; Gazzerro P; Portella G; Gerbasio D; Carella C; Matarese G; Bifulco M
J Mol Med (Berl); 2006 Nov; 84(11):967-73. PubMed ID: 16947002
[TBL] [Abstract][Full Text] [Related]
19. Statins ameliorate pulmonary hypertension secondary to left ventricular dysfunction through the Rho-kinase pathway and NADPH oxidase.
Chen IC; Tan MS; Wu BN; Chai CY; Yeh JL; Chou SH; Chen IJ; Dai ZK
Pediatr Pulmonol; 2017 Apr; 52(4):443-457. PubMed ID: 28029743
[TBL] [Abstract][Full Text] [Related]
20. Alteration of mevalonate pathway related enzyme expressions in pressure overload-induced cardiac hypertrophy and associated heart failure with preserved ejection fraction.
Chen B; Zhong LY; Yang JX; Pan YY; Chen F; Yang J; Wu T; Hu SJ
Cell Physiol Biochem; 2013; 32(6):1761-75. PubMed ID: 24356578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
